Evaluation of Resveratrol as a Dietary Supplement in Type 2 Diabetes Mellitus
Phase 4
- Conditions
- Health Condition 1: null- Type 2 Diabetes Mellitus
- Registration Number
- CTRI/2011/05/001731
- Lead Sponsor
- Dr MJ Nanjan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1.Male /female subjects with clinical diagnosis of Type 2 Diabetes Mellitus.
2.Age group of 30-70 years
3.Minimum 3 years of duration of disease.
4.Patients with at least 6 months of ongoing oral antidiabetic treatment.
5.Current ongoing medications like glibenclamide and metformin.
6.Patients who have the ability to comply with procedure.
7.Patients who are able to give consent for the study participation.
Exclusion Criteria
1.Pregnant or lactating women.
2.Paediatric population with Juvenile diabetes mellitus.
3.Type 1 diabetes Mellitus (IDDM).
4.Patients with any other co-morbidity and/or contraindication that may interfere with the study result.
5.Diabetic patients with significant hepatic, renal dysfunction and blood disorder.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method